Literature DB >> 14645603

Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5.

Barbara Salone1, Yuri Martina, Stefania Piersanti, Enrico Cundari, Gioia Cherubini, Laure Franqueville, Cristina M Failla, Pierre Boulanger, Isabella Saggio.   

Abstract

Many adenovirus serotypes enter cells by high-affinity binding to the coxsackievirus-adenovirus receptor (CAR) and integrin-mediated internalization. In the present study, we analyzed the possible receptor function of alpha3beta1 for adenovirus serotype 5 (Ad5). We found that penton base and integrin alpha3beta1 could interact in vitro. In vivo, both Ad5-cell binding and virus-mediated transduction were inhibited in the presence of anti-alpha3 and anti-beta1 function-blocking antibodies, and this occurred in both CAR-positive and CAR-negative cell lines. Peptide library screenings and data from binding experiments with wild-type and mutant penton base proteins suggest that the Arg-Gly-Asp (RGD) in the penton base protein, the best known integrin binding motif, is only part of the binding interface with alpha3beta1, which involved multiple additional contact sites.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645603      PMCID: PMC296057          DOI: 10.1128/jvi.77.24.13448-13454.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage.

Authors:  M Di Giovine; B Salone; Y Martina; V Amati; G Zambruno; E Cundari; C M Failla; I Saggio
Journal:  Virology       Date:  2001-03-30       Impact factor: 3.616

Review 2.  Integrin cell adhesion receptors and the concept of agonism.

Authors:  M J Humphries
Journal:  Trends Pharmacol Sci       Date:  2000-01       Impact factor: 14.819

3.  Integrin alpha(v)beta1 is an adenovirus coreceptor.

Authors:  E Li; S L Brown; D G Stupack; X S Puente; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 4.  Functions of alpha3beta1 integrin.

Authors:  J A Kreidberg
Journal:  Curr Opin Cell Biol       Date:  2000-10       Impact factor: 8.382

5.  Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.

Authors:  K Kasono; J L Blackwell; J T Douglas; I Dmitriev; T V Strong; P Reynolds; D A Kropf; W R Carroll; G E Peters; R P Bucy; D T Curiel; V Krasnykh
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

6.  The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.

Authors:  T Jackson; D Sheppard; M Denyer; W Blakemore; A M King
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection.

Authors:  J Qiu; K E Brown
Journal:  Virology       Date:  1999-11-25       Impact factor: 3.616

8.  Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors.

Authors:  K Triantafilou; M Triantafilou; Y Takada; N Fernandez
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells.

Authors:  Shaw M Akula; Naranatt P Pramod; Fu Zhang Wang; Bala Chandran
Journal:  Cell       Date:  2002-02-08       Impact factor: 41.582

10.  Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus.

Authors:  Terry Jackson; A Paul Mould; Dean Sheppard; Andrew M Q King
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

View more
  22 in total

1.  The E4orf6/E1B55K E3 ubiquitin ligase complexes of human adenoviruses exhibit heterogeneity in composition and substrate specificity.

Authors:  Chi Ying Cheng; Timra Gilson; Frédéric Dallaire; Gary Ketner; Philip E Branton; Paola Blanchette
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

2.  CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7.

Authors:  Marko Marttila; David Persson; Dan Gustafsson; M Kathryn Liszewski; John P Atkinson; Göran Wadell; Niklas Arnberg
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  Adenovirus receptors.

Authors:  Yuanming Zhang; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Octaarginine-modified multifunctional envelope-type nanoparticles for gene delivery.

Authors:  I A Khalil; K Kogure; S Futaki; S Hama; H Akita; M Ueno; H Kishida; M Kudoh; Y Mishina; K Kataoka; M Yamada; H Harashima
Journal:  Gene Ther       Date:  2007-02-01       Impact factor: 5.250

5.  Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors.

Authors:  Joshua J Short; Chenthamarakshan Vasu; Mark J Holterman; David T Curiel; Alexander Pereboev
Journal:  Virus Res       Date:  2006-08-22       Impact factor: 3.303

Review 6.  Current advances and future challenges in Adenoviral vector biology and targeting.

Authors:  Samuel K Campos; Michael A Barry
Journal:  Curr Gene Ther       Date:  2007-06       Impact factor: 4.391

7.  Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex.

Authors:  Frédéric Dallaire; Paola Blanchette; Peter Groitl; Thomas Dobner; Philip E Branton
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.

Authors:  Meredith A Preuss; Joel N Glasgow; Maaike Everts; Mariam A Stoff-Khalili; Hongju Wu; David T Curiel
Journal:  Open Gene Ther J       Date:  2008-01-01

9.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

Review 10.  Adenovirus receptors and their implications in gene delivery.

Authors:  Anurag Sharma; Xiaoxin Li; Dinesh S Bangari; Suresh K Mittal
Journal:  Virus Res       Date:  2009-02-26       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.